Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C21H21FO5S
CAS Number:
Molecular Weight:
404.45
NACRES:
NA.21
Assay:
≥98% (HPLC)
Form:
powder
Quality Segment
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
-10 to -25°C
SMILES string
O[C@H]1[C@@H](O[C@H](CO)[C@@H](O)[C@@H]1O)C2=CC(CC3=CC4=CC=CC=C4S3)=C(F)C=C2
Biochem/physiol Actions
Ipragliflozin is a potent and highly selective sodium-glucose cotransporter-2 (SGLT2) inhibitor, demonstrating excellent oral bioavailability with an IC50 of 1,876 nM for SGLT1and 7.38 nM for hSGLT2. Ipragliflozin features dose-dependent pharmacokinetics, effectively induces glucosuria, and has been shown to decrease blood glucose levels, reduce blood pressure, lower body weight, and diminish both hypoglycaemic risk and abdominal symptoms in diabetic patients. Additionally, Ipragliflozin increases insulin levels in the pancreas and prevents the loss of insulin-positive cells in islets of db/db mice. ASP-1941 also maintains a favourable safety profile as monotherapy and is compatible with other hypoglycaemic agents, such as sulphonyl urea, metformin, pioglitazone, and dipeptidyl peptidase-4 (DPP4) inhibitors. Ipragliflozin has been considered as an anti-obesity and anti-diabetic agent.
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.